Overview

PEP on a Skin Graft Donor Site Wound

Status:
Enrolling by invitation
Trial end date:
2022-03-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of a biological agent called PEP in people who have a skin graft donor site wound.
Phase:
Phase 1
Details
Lead Sponsor:
Steven L. Moran
Collaborator:
Rion LLC
Treatments:
Fibrin Tissue Adhesive